Article
The butyrylcholinesterase knockout mouse a research tool in the study of drug sensitivity, bio-distribution, obesity and Alzheimer's disease.
Expert opinion on drug metabolism & toxicology - 1 May 2009
Duysen Ellen G, Li Bin, Lockridge Oksana
Abstract excerpt
Butyrylcholinesterase (BChE) mutations common in the human population may result in complete or partial BChE deficiency, making the BChE knockout (KO) mouse a model for human deficiencies. The BChE KO mouse cannot tolerate standard doses of the muscle relaxant succinylcholine or the Alzheimer's disease drugs huperzine A and donepezil. It is resistant to the asthma drug bambuterol. The importance of BChE in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
